Prognostic impact of the acute reactiveness to intravenous administration of tolvaptan sodium phosphate in patients with acute decompensated heart failure
Intravenous tolvaptan sodium phosphate enhances decongestion and short-term outcomes in ADHF without worsening renal function. Early diuretic responsiveness is a robust prognostic marker.
Authors
- Hiroshi Iwata (ORCID: https://orcid.org/0000-0001-7098-9406)
- Tohru Minamino (ORCID: https://orcid.org/0000-0003-1627-6151)
- Soshi Moriya
- Norihito Takahashi (ORCID: https://orcid.org/0000-0002-7817-5973)
- Takatoshi Kasai (ORCID: https://orcid.org/0000-0001-5747-7668)
- Shohei Ouchi (ORCID: https://orcid.org/0009-0001-1744-1684)
- Ryo Naito
Institutions
- Juntendo University (JP)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1093/ehjopen/oeaf108
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00